Reliance Industries Hits ₹20-Lakh Crore Market Cap Milestone

Reliance Industries Limited (RIL) achieved a significant milestone on Indian stock exchanges by surpassing a market capitalization of ₹20-lakh crore. This marks the first instance of any company achieving this valuation on the Indian bourses. The surge in market value is attributed to various factors including robust performance across its business segments and favorable market conditions.

Financial Performance Overview

  • RIL shares reached a record high of ₹2,958 on the Bombay Stock Exchange (BSE), registering a 1.8% increase intraday.
  • The day concluded with RIL’s shares closing at ₹2,930, marking a 0.88% increase.
  • Year-to-date, RIL shares have gained 13.4%, while over the past year, they have surged by 26.1%.

Quarterly Results Highlights

  • In the third quarter ending December, RIL reported an operating profit of ₹40,660 crore, reflecting a robust year-on-year growth of 15.4%.
  • Earnings before interest, taxes, depreciation, and amortization (EBITDA) growth was primarily driven by the upstream oil & gas and retail segments.
  • The oil to chemicals segment experienced subdued growth due to planned maintenance and inspection shutdowns, impacting overall growth.
  • Reliance Jio witnessed continued growth with subscriber additions and increased data consumption.
  • Retail segment growth was broad-based, spanning various consumption baskets.

 

 

 

Piyush Shukla

Recent Posts

Women’s U19 T20 World Cup 2027 to Begin on January 21 in Bangladesh and Nepal

The ICC U19 Women’s T20 World Cup 2027 is set to commence on January 21,…

18 hours ago

World Iodine Deficiency Day 2026: Causes, Symptoms, Prevention and India’s NIDDCP

Iodine Deficiency Day or World Iodine Deficiency Disorders Prevention Day is celebrated on October 21…

19 hours ago

Nigeria Reports Imported Case of Ebola Bundibugyo Virus Disease

There is an imported case of the Bundibugyo strain of the Ebola virus in the…

19 hours ago

DCGI Approves Zytorvi (Toripalimab) for Advanced Esophageal Cancer

On October 21, 2026, the Drugs Controller General of India (DCGI) approved Zytorvi (toripalimab) in…

21 hours ago

Ipsos Quality of Care Perception Index 2026: Malaysia Ranks First, India Third

India was ranked third in the Ipsos Quality of Care Perception Index 2026 after Malaysia…

21 hours ago

Jamnagar Refinery: Why India’s Oil Hub Matters to the World

Jamnagar is a coastal city in the state of the Gujarat and it is emerging…

21 hours ago